January 09, 2020

Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer

Read More
October 17, 2019

Teneobio and Selexis Expand Relationship with Three Commercial License Agreements for Multi-specific Antibody Candidates in Oncology

Read More
September 17, 2019

Generium Launches First Biosimilar of Dornase Alfa; Becomes Sixth Approved Product Using Selexis SUREtechnology Platform

Read More

Media Downloads